| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.52B | 67.22B | 71.88B | 72.92B | 66.08B | 67.95B |
| Gross Profit | 13.35B | 12.56B | 12.71B | 13.69B | 12.13B | 12.85B |
| EBITDA | 5.20B | 4.55B | 5.14B | 6.04B | 5.03B | 5.76B |
| Net Income | 2.83B | 2.41B | 3.06B | 3.53B | 3.33B | 3.50B |
Balance Sheet | ||||||
| Total Assets | 57.16B | 57.74B | 54.74B | 52.81B | 51.71B | 51.97B |
| Cash, Cash Equivalents and Short-Term Investments | 18.79B | 18.15B | 19.64B | 19.46B | 20.72B | 17.72B |
| Total Debt | 653.00M | 707.00M | 0.00 | 0.00 | 4.00M | 286.00M |
| Total Liabilities | 23.28B | 23.17B | 20.70B | 20.68B | 21.10B | 23.17B |
| Stockholders Equity | 33.68B | 34.37B | 33.86B | 31.85B | 30.42B | 28.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.17B | 3.44B | 1.45B | 4.12B | 724.00M |
| Operating Cash Flow | 0.00 | 4.51B | 4.42B | 2.66B | 4.75B | 1.43B |
| Investing Cash Flow | 0.00 | -4.00B | -2.29B | -1.79B | -23.00M | -705.00M |
| Financing Cash Flow | 0.00 | -1.96B | -1.97B | -2.17B | -1.78B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥59.51B | 17.50 | ― | 2.01% | 14.48% | 122.79% | |
75 Outperform | ¥52.72B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
70 Outperform | ¥50.08B | 18.57 | ― | 3.53% | -2.95% | -35.66% | |
68 Neutral | ¥46.56B | 4.67 | ― | 2.26% | 12.93% | 98.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥46.89B | 20.04 | ― | 5.38% | -9.27% | -6.86% | |
60 Neutral | ¥60.74B | 19.35 | ― | 1.57% | 11.01% | 231.83% |